Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachael Sumner

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMC Neuroscience|June 30, 2023
Psychedelics and neural plasticityRachael Sumner, Kacper Lukasiewicz
Frontiers in Neuroendocrinology|July 31, 2020
Progesterone - Friend or foe?Inger Sundström-Poromaa, Erika Comasco, Rachael Sumner, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 20, 2025
The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysisKate Godfrey, Hannah Douglass, David Erritzoe, et al.
Journal of Chromatographic Science|November 19, 2025
A Novel Stability Indicating High Performance Liquid Chromatography Method for Lysergic Acid Diethylamide Quantification: From Microdosing Applications to Broader Analytical UseMahima Bansal, Estelle Miller, Rachael Sumner, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorderRebecca McMillan, Rachael Sumner, Anna Forsyth, et al.
Translational Psychiatry|April 15, 2024
LSD increases sleep duration the night after microdosingNathan Allen, Aron Jeremiah, Robin Murphy, et al.
Neuropharmacology|September 1, 2025
Qualitative Content Analysis of Expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measuresCarina Joy Donegan, Dimitri Daldegan-Bueno, Tehseen Noorani, et al.
JAMA Psychiatry|April 8, 2026
General Anesthesia and Discrete Components of Ketamine NeurophysiologyBen Deverett, Duan Li, Theresa R Lii, et al.
Biological Psychiatry|March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled TrialRobin J Murphy, Rachael Sumner, William Evans, et al.
Neuropharmacology|November 7, 2025
LSD microdosing in major depressive disorder: results from an open-label trialDimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Neuroscience|June 30, 2023
Psychedelics and neural plasticityRachael Sumner, Kacper Lukasiewicz
Frontiers in Neuroendocrinology|July 31, 2020
Progesterone - Friend or foe?Inger Sundström-Poromaa, Erika Comasco, Rachael Sumner, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 20, 2025
The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysisKate Godfrey, Hannah Douglass, David Erritzoe, et al.
Journal of Chromatographic Science|November 19, 2025
A Novel Stability Indicating High Performance Liquid Chromatography Method for Lysergic Acid Diethylamide Quantification: From Microdosing Applications to Broader Analytical UseMahima Bansal, Estelle Miller, Rachael Sumner, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorderRebecca McMillan, Rachael Sumner, Anna Forsyth, et al.
Translational Psychiatry|April 15, 2024
LSD increases sleep duration the night after microdosingNathan Allen, Aron Jeremiah, Robin Murphy, et al.
Neuropharmacology|September 1, 2025
Qualitative Content Analysis of Expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measuresCarina Joy Donegan, Dimitri Daldegan-Bueno, Tehseen Noorani, et al.
JAMA Psychiatry|April 8, 2026
General Anesthesia and Discrete Components of Ketamine NeurophysiologyBen Deverett, Duan Li, Theresa R Lii, et al.
Biological Psychiatry|March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled TrialRobin J Murphy, Rachael Sumner, William Evans, et al.
Neuropharmacology|November 7, 2025
LSD microdosing in major depressive disorder: results from an open-label trialDimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Pageof 2